Showing results (511-520 of 1,877) with videos related to
Sort By:
Pageof 188
Immunotherapy|October 26, 2017
Immune-related musculoskeletal toxicities among cancer patients treated with immune checkpoint inhibitors: a systematic reviewOmar Abdel-Rahman, Mostafa Eltobgy, Hani Oweira, et al.Immunotherapy|January 18, 2018
Immunotherapy of cancer: targeting cancer during active disease or during dormancy?Syed Ammer Shah, Melika Zarei, Saeed H Manjili, et al.Immunotherapy|January 18, 2018
Chemotherapy-induced immunomodulation in non-small-cell lung cancer: a rationale for combination chemoimmunotherapyHua Zheng, Masha Zeltsman, Marjorie G Zauderer, et al.Immunotherapy|February 10, 2018
Immune-based therapies for metastatic prostate cancer: an updateMd Kamal Hossain, Kamrun Nahar, Osaana Donkor, et al.Immunotherapy|February 10, 2018
Emerging immune targets for the treatment of multiple myelomaAtif Sohail, Adeela Mushtaq, Ahmad Iftikhar, et al.Immunotherapy|March 3, 2018
Tocilizumab in the treatment of adult rheumatoid arthritisRaimon Sanmartí, Virginia Ruiz-Esquide, Carla Bastida, et al.Immunotherapy|February 24, 2018
Tumor lysate particle loaded dendritic cell vaccine: preclinical testing of a novel personalized cancer vaccineMark O Hardin, Timothy J Vreeland, Guy T Clifton, et al.Immunotherapy|October 4, 2017
Expression analysis of cancer-testis genes in prostate cancer reveals candidates for immunotherapySepideh Faramarzi, Soudeh Ghafouri-FardImmunotherapy|October 4, 2017
Anti-CD 19 and anti-CD 20 CAR-modified T cells for B-cell malignancies: a systematic review and meta-analysisIrbaz Bin Riaz, Umar Zahid, Muhammad Umar Kamal, et al.Immunotherapy|September 8, 2017
Application of chimeric antigen receptor-engineered T cells in ovarian cancer therapyMinghui Zhang, Dr Bin Zhang, Huirong ShiPageof 188